Requires Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.

This bill (S 797) requires New Jersey Medicaid to cover ovulation-enhancing drugs and related medical services for eligible beneficiaries experiencing infertility. It directly affects low-income New Jersey residents enrolled in Medicaid who face infertility challenges. The key mechanism adds these fertility treatments to Medicaid's list of covered services under "medical care not included in subsection a.(5)," expanding existing coverage categories. The bill specifies coverage for the drugs themselves and associated medical services administered to manage infertility, without detailing specific eligibility thresholds beyond the beneficiary's infertility status.